Top.Mail.Ru
Myeloid Leukemia Treatment in Israel | Ichilov

Chronic Myeloid Leukemia Treatment in Israel

Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a type of cancer that starts in the blood-forming cells of the bone marrow and progresses slowly. It is also known as chronic myelogenous leukemia.

Israel is among the leading countries in the world for CML treatment, providing advanced diagnostic and treatment methods, as well as a team of highly skilled oncology specialists.

Chronic Myeloid Leukemia Symptoms

Some common symptoms of chronic myeloid leukemia include:

  • Fatigue and weakness
  • Unexplained weight loss
  • Night sweats
  • Fever
  • Joint and bone pain
  • Enlarged spleen (causing a feeling of fullness in the abdomen)
  • Anemia (low red blood cell count)

Risk factors for CML include age, gender (men are more likely to develop the disease), and exposure to high levels of radiation.

Chronic Myeloid Leukemia (CML) Diagnosis in Israel

At Ichilov Hospital, a comprehensive diagnostic process is employed to confirm the presence of CML. This includes:

  • Puncture biopsy of the bone marrow
  • Advanced analysis of peripheral blood
  • Genetic research
  • Polymerase chain reaction (PCR)
  • Bone marrow biopsy

Chronic Myeloid Leukemia Treatment Methods in Israel

Various treatment options are available for CML patients at Ichilov Hospital, such as:

Benefits and Effectiveness of Chronic Myeloid Leukemia Treatment at the Ichilov Clinic

The Ichilov Clinic is renowned for its state-of-the-art facilities, cutting-edge technology, and highly skilled oncology specialists. Patients who receive CML treatment in Israel benefit from:

  • Personalized treatment plans tailored to each patient’s specific needs

  • Access to the latest advancements in CML treatment

  • A multidisciplinary team of experts working together to provide comprehensive care

  • High success rates and improved quality of life for patients

FAQ

Chronic myeloid leukemia is a type of cancer that starts in the blood-forming cells of the bone marrow and progresses slowly.
CML is characterized by the presence of an abnormal chromosome called the Philadelphia chromosome, which leads to the production of a protein responsible for the uncontrolled growth of white blood cells.
The treatment for myelogenous leukemia includes chemotherapy, targeted therapy, biological treatments, and bone marrow transplantation.
In the terminal stage of CML, also known as the blast phase, immature white blood cells called blasts appear in the blood and bone marrow, crowding out healthy cells and leading to a rapid decline in the patient's condition.
Treatment options for CML include chemotherapy, targeted therapy, biological treatments, and bone marrow transplantation.
With proper treatment, many patients can live with CML for many years. The survival rate has significantly improved due to advancements in targeted therapies.
Whatsapp with a Doctor
Answer within 3 hours
Get a Quote NOW
Contact us